Sunday, September 27, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchcatestatinalzheimersneurodegenerationuc san diego

UC San Diego team reports catestatin cuts tau and amyloid in mice

The naturally occurring chromogranin A fragment also reduced brain inflammation and improved cognitive and motor function in mouse models, researchers say.

PR
By Priya Raman · Science Reporter
Sep 23 07:44 ETSource: Technology Networks

The wire

  1. 01Researchers at UC San Diego School of Medicine report that catestatin, a peptide derived from chromogranin A, reduced tau and amyloid accumulation and neuroinflammation in mouse models of neurodegeneration.
  2. 02Senior author Sushil K. Mahata says the peptide acts across several disease pathways at once, a contrast with single-target approaches in Alzheimer's drug development.
  3. 03Work remains in mice; the team says it is still investigating whether catestatin changes how the brain produces and uses energy, and no human data exist.

From the source

One Small Peptide Could Tackle Multiple Neurodegenerative Diseases

We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Read at technologynetworks.com
PeptiPrescribed peptides from $99/moSee all →